AVT04

· Alvotech Swiss AG

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AVT04, covering 2023-02-02 to 2023-02-02. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy, Safety, and Immunogenicity of AVT04 With Moderate-to-Severe Chronic Plaque Psoriasis [Phase 3]